Telesis Bio, Inc. (TBIO) earnings
Quarterly and annual TBIO reports and results, each read against the price at its own news timestamp. Back to the TBIO overview →
7 measured TBIO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Telesis Bio Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.80% | -12.00% | |
| Form 10-Q Telesis Bio Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -13.33% | |
| Form 10-Q Telesis Bio Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.74% | -5.54% | |
| Telesis Bio Reports First Quarter 2024 Financial Results | Press release | -0.74% | -5.54% | |
| Form 10-K Telesis Bio Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.30% | |
| Form 10-Q Telesis Bio Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.00% | -0.24% | |
| Telesis Bio Reports Third Quarter 2023 Financial Results | Press release | -1.00% | -0.24% |
Keep exploring
More TBIO: analyst actions → · SEC filings → · TBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ENZON PHARMS INC (ENZN) | 93 | 0.00% | 23% |
| HEMACARE CORP (HEMA) | 91 | 0.00% | 23% |
| Trevena, Inc. (TRVN) | 91 | 0.00% | 46% |
| CV SCIENCES INC (CVSI) | 90 | +0.59% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.